About the LUCE-1 Trial LUCE-1 is a Phase 1/2 multicenter, open-label, dose escalation study investigating safety, tolerability and preliminary efficacy of 3 dose levels of dual AAV8.MYO7A (AAVB-081) ...
Discovery of genetic glitches in gene formatting (RNU4-2 mutations) discloses a new cause for blindness, solving retinal ...
In patients with retinitis pigmentosa (RP), crucial cells in the retina known as rods and cones die over time; night ...
News Medical on MSN
Why Some Retinitis Pigmentosa Cases Went Undiagnosed for Decades
Researchers led by the Institute of Molecular and Clinical Ophthalmology Basel uncovered disease-causing variants in ...
Researchers from Radboud University Medical Center and University of Basel have discovered new genetic causes of inherited ...
Several genes have been identified for each of the forms of RP (refs 3–16,), but most RP genes are still uncloned and known only through linkage studies ( http ...
This work not only identified the genetic cause of RP but also further highlights the role that noncoding genes can have in genetic disorders.
Retinitis pigmentosa, a degenerative genetic disease of the eye, is characterized by progressive vision loss, usually leading to blindness. In some patients, structural defects in the photoreceptor ...
Retinitis pigmentosa, a degenerative genetic disease of the eye, is characterized by progressive vision loss, usually leading to blindness. In some patients, structural defects in the photoreceptor ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted rare pediatric disease designation to VG901 for retinitis pigmentosa. An independent data safety ...
Diagnosed with retinitis pigmentosa, Anne Hatton Ogden uses cooking as a form of therapy. With guide dog Angelo and assistive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback